Odonate Therapeutics shares to be delisted from Nasdaq

Jan. 07, 2022 9:20 AM ETOdonate Therapeutics, Inc. (ODTC)By: Pranav Ghumatkar, SA News Editor
  • Odonate Therapeutics (NASDAQ:ODT) plummets 39% premarket as it expects the trading of its common stock on Nasdaq to be suspended at the opening of business on Jan. 18, 2022.
  • The Co. has announced that on Jan. 6, 2022 it received written notice from The Nasdaq

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.